" OFFICIAL LANGUAGE OF THC 3 IS ENGLISH"
>>>>>>ORAL PRESENTATIONS <<<<<< Main Hall, Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
FIRST DAY, 6 OCTOBER 2010
| Date/Time | Lecturer | Title |
|---|---|---|
| 8:00-8:20 | Opening Ceremony and start of Registration Desk | |
| 8:20-8:25 | Prof. Alavian | Introduction of Governing Board |
| 8:25-8:45 | Prof. Yalda | Begining of the Congress: Ethics and Medicine |
| SESSION 1 ------------ |
Chairmen: Prof. P Karayiannis Prof. MR Zali Prof. R Malekzadeh |
HBV Infection: Epidemiology & Prevention |
| 8:45-9:00 | Prof. Mohammad Reza Zali | Epidemiology of Hepatitis B in Iran: New Approach |
| 9:00-9:20 | Prof. Daniel Olivier Lavanchy | Preparedness for Epidemics |
| 9:20-9:35 | Prof. Kamran Bagheri Lankarani | Efficacy of Hepatitis B Vaccination in Prisoners: A Comparison of Accelerated vs. Classic Vaccination Protocols |
| 9:35-9:55 | Prof. Michael Roggendorf | Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck |
| 9:55-10:30 | >>>International KOWSAR award and HepatMon Best Associate Editors<<<< | |
| 10:30-10:45 | ...: Break :... | |
| SESSION 2 ------------ |
Chairmen: Prof. FB Hollinger Prof. KB Lankarani Prof. M Roggendorf |
Chronic Hepatitis B: Diagnosis & Treatment |
| 10:45-11:05 | Prof. Peter Karayiannis | Molecular Targets and Immunological Pathways in Chronic HBV Infection |
| 11:05-11:20 | Prof. Reza Malekzadeh | When to Treat Subjects with Minimally Active Chronic HBV? |
| 11:20-11:35 | Prof. Mehdi Saberi-Firoozi | Treatment Of Hepatitis B Virus (Hbv)-Related Liver Cirrhosis |
| 11:35-12:00 | Prof. F.Blaine Hollinger | Occult Hepatitis B in Blood Donors: Transmission Concerns |
| 12:00-12:20 | Q&A | |
| 12:20-13:20 | ...: Prayer, Lunch :... | |
| SESSION 3 ------------ |
Chairmen: Prof. KB Lankarani Prof. M Umar Prof. SM Alavian |
Chronic Hepatitis C: Diagnosis & Treatment |
| 13:25-13:40 | Prof. Muhammad Umar | Treatment Response Of Chronic Hepatitis C Patients In Pakistan |
| 13:40-13:55 | Prof. Houri Rezvan | Hepatitis C Virus (HCV) Testing For Diagnosis And Interpretation Of Results |
| 13:55-14:10 | Prof. SM Alavian | Iranian Experience with Pegasys Therapy in HCV Infection in Hemophilia and Thalassemia: A National Study |
| 14:10-14:25 | Dr. Keyvani | Molecular Diagnosis Of Hepatitis B and Hepatitis C Viruses |
| 14:25-14:40 | Dr. Saeid Ghavami | Role of Autophagy in HCV and HBV: Possible New Therapeutic Approach |
| 14:40-15:00 | Q&A | |
| 15:00-15:30 | ...: Break :... | |
| 15:30-15:50 | Prof. Aamir Ghafoor Khan | Shorter Course of Treatment for Hepatits C Patients |
| 15:50-16:05 | Dr. Mohammad Minakari | Chronic Hepatitis C: Management Of Non-Responders and Relapsers |
| 16:05-16:20 | Q&A |
Main Hall, Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
SECOND DAY, 7 OCTOBER 2010
| Date/Time | Lecturer | Title |
|---|---|---|
| SESSION 1 ------------ |
Chairmen: Prof. AG Khan Prof. D Lavanchy Prof. MR Zali |
HCV Infection: Epidemiology & Prevention |
| 8:15-8:40 | Prof. Daniel Lavanchy | The Global Epidemiology of Hepatitis C |
| 8:40-9:00 | Prof. Muhammad Umar | Burden and Mode of Transmission of Hepatitis C in Pakistan |
| 9:00-9:20 | Dr. Azzam Kayasseh | Viral Hepatitis C in UAE |
| 9:20-9:35 | Dr. M Naghipour | Epidemiology of Hepatitis C Infection in Iran and the Region: Lessons Should Be Learned |
| 9:35-9:50 | Dr. Sedigheh Amini Kafi-abad | Blood Safety in Iran, 2004-2009 |
| 9:50-10:05 | Q & A | |
| 10:05-10:35 | ...: Break :... | |
| SESSION 2 ------------ |
Chairmen: Prof. NE Daryani Prof. M Umar Prof. H Forootan |
Management of Chronic Hepatitis B Infection |
| 10:35-10:50 | Dr. Bita Behnava | Peginterferon for the Treatment of Chronic Hepatitis B |
| 10:50-11:05 | Prof. Hossein Forootan | Clinical Treatment and Management of Chronic Hepatitis B |
| 11:10-11:25 | Dr. Seyed-Mohammad Jazayeri | Molecular Epidemiology Study and Genotypes of HBV in Iranian Populations; A National Based Survey |
| 11:25-11:40 | Dr. Ashraf Mohamadkhani | Hepatitis B Virus Genome Diversity in the Basal Core Promoter Region |
| 11:40-11:55 | Dr. Alavi Moghadam | An Iranian International Study in Interferon Experiences |
| 11:55-12:10 | Dr. Pouryasin | Molecular Resistance of HBV Infected Patients, Iranian Experiences |
| 12:10-12:35 | Q&A | |
| 12:35-13:35 | ...: Prayer & Lunch :... | |
| SESSION 3 ------------ |
Chairmen: Prof. NE Daryani Dr. SM Jazayeri Dr. Mansouri |
HBV infection (A-Z) |
| 13:40-13:55 | Dr. Mitra Mahdavi Mazdeh | Hepatitis B and C in Dialysis Units in Iran |
| 13:55-14:10 | Prof . Naser Ebrahimi Daryani | Drug Induced Liver Injury |
| 14:10-14:25 | Dr. Farhad Fathimoghadam | The Prevalence of Hepatitis B Antigen-Positivity in the General Population of Mashhad, Iran |
| 14:25-14:40 | Dr. Mohammad Hossein Somi | Prevention of Hepatitis B in Hemodialysis Patients |
| 14:40-15:00 | Dr. Siavash Mansouri | Applications of UES in Liver Disease |
| 15:00-15:15 | Dr. Mahmood Nabavi | Prevention Strategies in Control of HBV in Iran |
| 15:15-15:30 | Prof. Behzad Einollahi | Hepatitis C Virus Infection and Kidney Transplantation: Treatment |
| 15:30-15:45 | Q&A |
Main Hall, Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
THIRD DAY, 8 OCTOBER 2010
| Date/Time | Lecturer | Title |
|---|---|---|
| SESSION 1 ------------ |
Chairmen: Prof. M Rizzetto Prof. M Roggendrof Prof. SM Alavian |
Hepatitis D infection |
| 8:00-8:25 | Prof. Mario Rizzetto | Current Epidemiology and Clinical Features of Hepatitis D in Europe and Asia |
| 8:25-8:40 | Prof. Seyed Moayed Alavian | Epidemiology of HDV in I.R. Iran |
| 8:40-8:55 | Dr. Maryam Keshvari | Iranian Experience with Chronic Hepatitis Delta Management: A Preliminary Report |
| 8:55-9:10 | Mr. Hadi Karimzadeh | Applications of Molecular Tests in Serodiscordant Viral Hepatitis B-Infected Patients |
| 9:10-9:30 | Q&A | |
| 9:30-10:00 | ...: Break :... | |
| SESSION 2 ------------ |
Chairmen: Prof. H Forootan Prof. FB Hollinger Prof. SM Alavian |
Autoimmune Hepatitis & MicroRNA |
| 10:00-10:15 | Dr. Abolfazl Iranikhah | Cyclosporine Use in AIH/Update |
| 10:15-10:30 | Dr. Seyyed Mohammad Miri | The Role of MicroRNAs in Liver Diseases: A Brilliant New Attitude towards Diagnosis and Treatment |
| 10:30-10:50 | Prof. F Blaine Hollinger | Will Hepatitis E Virus Become an Emerging Infectious Disease? |
| 10:50-11:10 | Prof. Michael Roggendorf | Acute Hepatitis A is Associated with a Multispecific CD8+ T Cell Response in HLA-A2 Positive Patients |
| 11:10-11:25 | Dr. Farhad Zamani | Iron Overload and Response To Anti-HCV Therapy in Patients with Chronic HCV |
| 11:25-11:55 | Q&A | |
| 12:00-13:00 | ...: Prayer & Lunch :... | |
| SESSION 3 ------------ |
Chairmen: Prof. F Mansour-Ghanaei Prof. FB Hollinger |
HCV in Blood-Borne Disorders |
| 13:00-13:15 | Prof. F Mansour-Ghanaei | Hcv Infection in Patients with Persistently Normal Serum Aminotransferases (PNALT) |
| 13:15-13:30 | Dr. Azita Azarkeivan | Evaluation of HCV Infection in Multi Transfused Thalassemic Patients and Trace Backing of the New Cases Adult Thalassemia Clinic, Tehran |
| 13:30-13:45 | Dr. Fariba Seighali | The Latest Treatment Options for Children with Hepatitis C |
| 13:45-14:00 | Mrs. Farah Bokharaei Salim | Occult Hepatitis C Virus Infection in Iranian Patients with Chronic Liver Disease with Unknown Etiology |
| 14:00-14:15 | Q&A | |
| 14:15-14:30 | ...: End of Tehran Part :... |
Sina & Sadra Hall, Shiraz Medical University, Shiraz, IRAN
FOURTH DAY, 9 OCTOBER 2010
| Date/Time | Lecturer | Title |
|---|---|---|
| SESSION 1 ------------ |
Chairmen: Prof. HA Malek Hosseini, Dr. Nik Eghbalian |
Liver Transplantation |
| 8:00-8:15 | Opening Ceremony | |
| 8:15-8:35 | Dr. Nik Eghbalian | Liver TransplantationLiver Transplantation in Iran: A 15 Year Experience |
| 8:35-8:55 | Dr. Maryam Moeini | Liver Transplantation for Inherited Metabolic Disorders of the Liver |
| SESSION 2 ------------ |
Chairman: Prof. KB Lankarani |
Viral Hepatitis |
| 8:55-9:15 | Prof. Mohammad Hadi Imanieh | Hepatitis B and C Epidemiology in Fars Province, 2009 |
| 9:15-9:35 | Prof. Kamran Bagheri Lankarani | Preventive Measures in Viral Hepatitis |
| 9:35-9:55 | Prof. Hollinger | Management of Hepatitis B: Treatment Options and Resistance Issues |
| 9:55-10:15 | Prof. Seyed Moayed Alavian | When Should Hepatitis B Not Be Treated? |
| 10:15-10:45 | ...: Break :... | |
| SESSION 3 ------------ |
Chairman: Prof. P Karayiannis |
Hepatocellular Carcinoma & Other Liver Diseases |
| 10:45-11:00 | Prof. Mahmood Haghighat | Autoimmune Hepatitis in Children |
| 11:00-11:25 | Prof. Peter Karayiannis | Expectations for Curative Anti-HBV Treatment and HCC Prevention |
| 11:25-12:00 | Prof. Mario Rizzetto | The Emerging Challenge of HBV Reactivation with Immunosuppressive Therapies |
| 12:00-12:15 | Dr. Mohammad Amin Poorhosseingholi | Burden of HCC in I.R. Iran |
| 12:15-12:35 | Q & A | |
| 12:35-12:55 | Dr. Saeid Ghavami | Alpha 1 Antitrypsin Deficiency: Molecular and Cellular Aspects |
| 12:55-13:15 | Prof. Aamir Ghafoor Khan | Acute Hepatitis B |
| 13:15-13:30 | Conclusion, Q & A |
>>>>>>WORKSHOPS <<<<<< All Workshops will be held in 2nd Floor of Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
6 Oct. 2010: 9 -12 am
Meta-Analysis Workshop Details
| Date/Time | Lecturer | Title |
|---|---|---|
| Moderator: Dr. Haghdoost |
||
| 9:00-10:00 | Dr. Haghdoost | Meta-Analysis-Part 1 |
| 10:00-10:30 | Break for participating in KOWSAR Award | |
| 10:30-12:30 | Dr. Haghdoost | Meta-Analysis-Part 2 |
6 Oct.. 2010: 1 -4 pm
Scientific Writing and EndNote Workshop Details
| Date/Time | Lecturer | Title |
|---|---|---|
| Moderator: Dr. Miri |
Scientific Writing and EndNote Workshop | |
| 1:00- 2:30 | Prof. Peter Karayiannis | Scientific Writing |
| 2:30- 4:00 | Dr. SM Miri | EndNote |
7 Oct. 2010 : 9 - 12 am
Molecular Diagnosis Workshop 1 Details
| Date/Time | Lecturer | Title |
|---|---|---|
| Moderator: Dr. Keyvani |
||
| 9:00-9:40 | Hadi Karimzadeh | Molcular Tests in Diagnosis of Hepatitis |
| 9:40-10:30 | Dr. Farah Bokharaei Salimi | Extraction of HBV-DNA and HCV-RNA from Serum by PBMC |
| 10:30-11:35 | Dr. Hossein Keyvani | Qualitative PCR & Quantitative PCR |
| 11:35-12:00 | Q & A |
7 Oct. 2010: 1 - 4 pm
Apoptosis and Autophagy Workshop Details
| Date/Time | Lecturer | Title |
|---|---|---|
| Chairman: Dr. Ghavami |
||
| 13:00-14:30 | Dr. Ghavami | Apoptosis |
| 14:30-16:00 | Dr. Ghavami | Autophagy |
>>>>>>POSTER PRESENTATIONS <<<<<<
First Session, 6 Oct. 2010, 9:00- 12:00 am, Main Hall, Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
| Date/Time | Lecturer | Title |
|---|---|---|
| 11:00-12:00 | Dr. Mohammad Kazemi Arababadi | Common HBV Genotype in South-Eastern Iranian Patients |
| 11:00-12:00 | Prof. Zahra Mohtasham Amiri | A Population-Base Survey of Past Hepatitis A Infections among Adults of Urban Area in North of Iran - 2009. |
| 11:00-12:00 | Dr. Afarin Rahimi-Movaghar | Correlates of Hepatitis C and B Virus Infections among Injecting Drug Users in Tehran, Iran |
| 11:00-12:00 | Dr. Mohammad Rostami Nejad | Coeliac Disease in Chronic Liver Diseases |
| 11:00-12:00 | Mrs. Rubina Sabir | Prevalence of Hepatitis C in Pregnant Women of Low Socioeconomic Area of Karachi |
| 11:00-12:00 | Miss. Mahrou Sadri | Cloning and Expression of NS3 Helicase Fragment of Hepatitis C Virus in "pET102/D-TOPO" Expression Vector |
| 11:00-12:00 | Dr. Shahnaz Sali | Influence of HBV Genotype and Genetic Diversity on Chronic HBV Outcome |
| 11:00-12:00 | Mrs. Forough Azam Tarabadi | Comparison of Serum BETA 2-Microgloubulin( β2-MG) Levels in HBsAG Positive and Negative Blood Donors |
| 11:00-12:00 | Dr. Mohammad Kazemi Arababadi | Analysis of Association between IL-12, IL-4 and IFN Polymorphisms with Occult HBV Infection |
| 11:00-12:00 | Dr. Abbas Allami | Needle Stick Injury in Nurses: Knowledge, Practice and Exposure to Hepatitis B |
| 11:00-12:00 | Dr. Mohammad Kazemi Arababadi | Are FasLigand Polymorphisms Associated with Occult HBV Infection? |
| 11:00-12:00 | Dr. Sedigheh Amini Kafi-Abad | Comparison of Two Commercial Screening Assays for Diagnosis of Hepatitis B Surface Antigen |
Second Session, 6 Oct. 2010, 13:00- 16:00 am, Main Hall, Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
| Date/Time | Lecturer | Title |
|---|---|---|
| 13:30 -14:30 | Dr. Atefeh Ghanbari | Comparative Study of Health Related Quality of Life in Patients with Hepatitis C and Healthy People and Present a Structural Model |
| 13:30 -14:30 | Mrs. Farahnaz Joukar | Knowledge and Attitude of Health Care Professionals' toward Caring for People with Hepatitis C |
| 13:30 -14:30 | Mrs. Farahnaz Joukar | The Frequency of Symptoms of Autoimmune Hepatitis in Admitted Patients of GI Ward of Razi Hospital from April 2006 to April 2009 |
| 13:30 -14:30 | Mrs.Farahnaz Joukar | What Are Hepatitis B Infected Person Problems in the Community |
| 13:30 -14:30 | Mr. Foad - Amanollahi | Prevalence of Common Types of Hepatitis C Virus Genotypes and the Relation between Age, Sex and Transmission Risk Factors in Kerman , Iran |
| 13:30 -14:30 | Dr. Leila Kasraian | The Prevalence Rate and Risk Factor of Hepatitis C in Shiraz Blood Donors in 2007 |
| 13:30 -14:30 | Dr. Enayatollah Nemat Khorasani | Outcome in Pediatric Autoimmune Hepatitis |
| 13:30 -14:30 | Dr. Nima Mahboobi | Dental Treatment as a Risk Factor for Hepatitis B and C Viral Infection: A Systematic Review |
| 13:30 -14:30 | Mr. Mahabady | Characterization of Drug-Related Mutations in Hepatitis B Virus Partial Reverse Transcriptase Sequences in Treatment-Naïve Iranian Patients |
| 13:30 -14:30 | Dr. Yunes Panahi | Investigation of the Effects of Chlorella Vulgaris Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial |
| 13:30 -14:30 | Dr. Sedigheh Amini Kafi-Abad | Comparison of Two Commercial Screening Assays for Diagnosis of Hepatitis C |
| 13:30 -14:30 | Dr. Mansour Ghanaei | The Survey of Thyroid Function Tests in Hepatitis B and C Induced Cirrhosis in Patients |
Third Session, 7 Oct. 2010, 9:00- 12:00 am, Main Hall, Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
| Date/Time | Lecturer | Title |
|---|---|---|
| 11:00-12:00 | Prof. Gholamali Ghorbani | Hepatitis A Virus Infection in Military Forces of the World |
| 11:00-12:00 | Prof. Gholamali Ghorbani | Occult B Hepatitis Infection |
| 11:00-12:00 | Miss. Maryam Farahani | Prevalence of Hepatitis C and B Virus Infection in Lymphoproliferative Disorders Patients |
| 11:00-12:00 | Prof. Seyed-Moayed Alavian | Meta-Analysis; Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for Treatment of Chronic HCV Infection |
| 11:00-12:00 | Dr. Farzin Roohvand | Role of Cellular Tubulin and Viral Nucleocapsid Protein Interactions in Hepatitis C Virus Infection |
| 11:00-12:00 | Dr. Narina Sargsyants | Clinical Aspects of Chronic HCV-Infection in Armenia |
| 11:00-12:00 | Dr. Narina Sargsyants | Epidemiology of Viral Hepatitis C in Armenia |
| 11:00-12:00 | Dr. Seyyed Yasser Saidi Hosseini | Long Term Efficacy of Combination Lamivudine and Adefovir in Patients with Chronic Hepatitis B |
| 11:00-12:00 | Dr. Fatemeh Alsadat Nobakht | Study of Prevalence of Transmitted Viral Infections in Regular and Non-Regular Donors of Yazd Blood Center in 1378-1388 |
| 11:00-12:00 | Miss. Parisa Meysami | Preliminary Report of HDV Genotypes in Iran |
| 11:00-12:00 | Dr. Mohsen Akhondi-meybodi | Conventional Versus Pegylated Interferons in Treatment of HCV Patients |
| 11:00-12:00 | Dr. Reza Jafari Shakib | Seroprevalence of Hepatitis E Virus Infection in Urban Area of Guilan Province |
Fourth Session, 7 Oct. 2010, 13:00- 16:00 am, Main Hall, Imam Ali Congress center, Shahid Behshti Medical University, Tehran, IRAN
| Date/Time | Lecturer | Title |
|---|---|---|
| 13:30 -14:30 | Dr. Seyed Mohammadmehdi Hosseini-Moghaddam | A Case-Control Study of Hepatitis B, C, and D in Hemodialysis Patients in Provinces of Iran |
| 13:30 -14:30 | Dr. Mahtab Vaziri | Seroprevalence of Hepatitis B,C and HIV Infections in Yazd Blood Donors |
| 13:30 -14:30 | Dr. Arash Mahboubi | Aluminum Salts in Recombinant Hepatitis B Vaccine. |
| 13:30 -14:30 | Dr. Mohammad Kazemi Arababadi | Evaluation of CCR5 Expression on NK Cells in Iranian Patients with Occult Hepatitis B Infection |
| 13:30 -14:30 | Dr. Mohammad Kazemi Arababadi | Decreased Expression of CCR5 on the Peripheral Blood CD8+ T Cells in Occult Hepatitis B Infected Patients |
| 13:30 -14:30 | Dr. Mohammad Kazemi Arababadi | Serum Levels of Interleukin (IL)-10 and IL-17A in Occult HBV Infected South-East Iranian Patients |
| 13:30 -14:30 | Dr. Mohammad Kazemi Arababadi | Association of Exon 9 but Not Intron 8 VDR Polymorphisms with Occult HBV Infection in South-Eastern Iranian Patients |
| 13:30 -14:30 | Dr. Mohammad Reza Ghadir | The Relationship between Lipid Profile and Severity of Liver Damage in Cirrhotic Patients Admitted into a Referal Hospital in Qom, Central Iran, During 2005 to 2008 |
| 13:30 -14:30 | Dr. Mohammad Kazemi Arababadi | Hepatitis B Virus Genotype, HBs Ag Mutations and Co-Infection wih HCV in Occult HBV Infection |
| 13:30 -14:30 | Dr. Hassan Fallah Huseini | The Effects of Cynara Scolymus L. Leaf and Cichorium Intybus L. Root Extracts on Carbon Tetrachloride Induced Liver Toxicity in Rats |
| 13:30 -14:30 | Dr. Alijan Tabarraei | Seroepidemiologic Assessment of Hepatitis E Virus in Pregnant Women, Gorgan |
